zonisamide has been researched along with Bronze Diabetes in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide was chosen for treatment of secondary paroxysmal dystonia in a patient with pyruvate dehydrogenase deficiency (case 1) and in two patients with neonatal hemochromatosis and family history of neonatal hemochromatosis (cases 2 and 3)." | 1.36 | Zonisamide ameliorates symptoms of secondary paroxysmal dystonia. ( Borenstein, MJ; Egel, RT; Hoganson, GE; Katerji, MA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egel, RT | 1 |
| Hoganson, GE | 1 |
| Katerji, MA | 1 |
| Borenstein, MJ | 1 |
1 other study available for zonisamide and Bronze Diabetes
| Article | Year |
|---|---|
Zonisamide ameliorates symptoms of secondary paroxysmal dystonia.
Topics: Adolescent; Antioxidants; Child; Dystonic Disorders; Female; Hemochromatosis; Humans; Isoxazoles; Ma | 2010 |